SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.530
+0.060 (1.73%)
At close: Apr 28, 2026, 4:00 PM EDT
3.650
+0.120 (3.40%)
Pre-market: Apr 29, 2026, 7:47 AM EDT
SAB Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | 13.27 | -34.11 | -42.19 | -18.74 | -17.14 | Upgrade
|
| Depreciation & Amortization | 3.08 | 4.79 | 3.75 | 3.29 | 1.65 | Upgrade
|
| Other Amortization | 0.26 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.04 | -0.02 | -0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.07 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 5.21 | 2.94 | 2.42 | 2.67 | 2.31 | Upgrade
|
| Other Operating Activities | -62.84 | -5.62 | 8.53 | -10.43 | 3.49 | Upgrade
|
| Change in Accounts Receivable | - | - | 5.56 | 2.45 | 12.56 | Upgrade
|
| Change in Accounts Payable | 1.48 | 0.92 | -2.7 | -0.78 | -2.94 | Upgrade
|
| Change in Unearned Revenue | - | -1.32 | 1.32 | -0.1 | - | Upgrade
|
| Change in Other Net Operating Assets | -5.17 | -1.9 | -1.85 | -1.81 | 2.06 | Upgrade
|
| Operating Cash Flow | -44.78 | -34.29 | -25.12 | -23.46 | 1.99 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -80.14% | Upgrade
|
| Capital Expenditures | -0.93 | -0.34 | -0.2 | -2.17 | -10.94 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | 0.04 | 0.08 | - | Upgrade
|
| Investment in Securities | -120.77 | -11.63 | - | - | - | Upgrade
|
| Investing Cash Flow | -121.71 | -11.96 | -0.15 | -2.09 | -10.94 | Upgrade
|
| Long-Term Debt Issued | - | 0.52 | 0.77 | 1.24 | 2.84 | Upgrade
|
| Long-Term Debt Repaid | -0.42 | -1.42 | -1.16 | -2.42 | -1.3 | Upgrade
|
| Total Debt Repaid | -0.42 | -1.42 | -1.16 | -2.42 | -1.3 | Upgrade
|
| Net Debt Issued (Repaid) | -0.42 | -0.91 | -0.39 | -1.19 | 1.54 | Upgrade
|
| Issuance of Common Stock | 168.73 | 0.02 | 59.66 | 7.76 | 0.01 | Upgrade
|
| Repurchase of Common Stock | -0.01 | -0.02 | - | - | - | Upgrade
|
| Other Financing Activities | -0 | -0.26 | - | -5.52 | 34.34 | Upgrade
|
| Financing Cash Flow | 168.3 | -1.17 | 66.77 | 1.05 | 35.89 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.21 | -0.24 | 0.02 | - | - | Upgrade
|
| Net Cash Flow | 1.6 | -47.67 | 41.52 | -24.5 | 26.93 | Upgrade
|
| Free Cash Flow | -45.71 | -34.63 | -25.32 | -25.63 | -8.96 | Upgrade
|
| Free Cash Flow Margin | - | -2618.65% | -1130.71% | -107.20% | -14.71% | Upgrade
|
| Free Cash Flow Per Share | -0.74 | -3.74 | -4.58 | -5.89 | -3.28 | Upgrade
|
| Cash Interest Paid | 0.24 | 0.37 | 0.25 | 0.29 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.03 | - | Upgrade
|
| Levered Free Cash Flow | -21.99 | -22.1 | -17.95 | -14.29 | 3.28 | Upgrade
|
| Unlevered Free Cash Flow | -22.1 | -21.91 | -17.75 | -14.1 | 3.46 | Upgrade
|
| Change in Working Capital | -3.69 | -2.3 | 2.33 | -0.24 | 11.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.